• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常规暴露前狂犬病预防:重新评估

Routine pre-exposure rabies prophylaxis: a reassessment.

作者信息

Mann J M

出版信息

Am J Public Health. 1984 Jul;74(7):720-2. doi: 10.2105/ajph.74.7.720.

DOI:10.2105/ajph.74.7.720
PMID:6742259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1651686/
Abstract

The rational use of rabies biologics is a difficult challenge. Pre-exposure rabies prophylaxis (PRE-RP) is one important rabies prevention strategy currently recommended by the US Public Health Service for groups considered at high risk of exposure to rabies. However, standard post-exposure rabies prophylaxis (POST-RP) appears equally effective in preventing rabies; PRE-RP still requires a limited vaccination series if a rabies exposure occurs and, at current costs, standard POST-RP may be a less expensive strategy than PRE-RP. For PRE-RP, as with other human rabies prevention strategies, the central problem is to obtain reasonable estimates of actual rabies exposure risks, which provide the rationale for well-designed programs.

摘要

合理使用狂犬病生物制品是一项艰巨的挑战。暴露前狂犬病预防(PRE-RP)是美国公共卫生服务部目前推荐给被认为有高狂犬病暴露风险人群的一项重要狂犬病预防策略。然而,标准的暴露后狂犬病预防(POST-RP)在预防狂犬病方面似乎同样有效;如果发生狂犬病暴露,PRE-RP仍需要有限的疫苗接种系列,并且以目前的成本计算,标准的POST-RP可能是比PRE-RP更便宜的策略。对于PRE-RP,与其他人类狂犬病预防策略一样,核心问题是获得对实际狂犬病暴露风险的合理估计,这为精心设计的方案提供了依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/1651686/f8847f47d59e/amjph00630-0081-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/1651686/f8847f47d59e/amjph00630-0081-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09b3/1651686/f8847f47d59e/amjph00630-0081-a.jpg

相似文献

1
Routine pre-exposure rabies prophylaxis: a reassessment.常规暴露前狂犬病预防:重新评估
Am J Public Health. 1984 Jul;74(7):720-2. doi: 10.2105/ajph.74.7.720.
2
Intradermal rabies vaccination: the evolution and future of pre- and post-exposure prophylaxis.皮内狂犬病疫苗接种:暴露前和暴露后预防的演变和未来。
Curr Top Microbiol Immunol. 2012;351:139-57. doi: 10.1007/82_2010_121.
3
Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost?旅行者的暴露前狂犬病预防:益处是否值得成本?
Vaccine. 1991 Nov;9(11):833-6. doi: 10.1016/0264-410x(91)90221-q.
4
Human rabies prevention--United States, 2008: recommendations of the Advisory Committee on Immunization Practices.2008年美国人类狂犬病预防——免疫实践咨询委员会的建议
MMWR Recomm Rep. 2008 May 23;57(RR-3):1-28.
5
The role of vaccination in rabies prevention.疫苗接种在狂犬病预防中的作用。
Curr Opin Virol. 2012 Jun;2(3):309-14. doi: 10.1016/j.coviro.2012.03.007. Epub 2012 Apr 11.
6
Cost comparison of rabies pre-exposure vaccination with post-exposure treatment in Thai children.泰国儿童狂犬病暴露前预防接种与暴露后治疗的成本比较
Vaccine. 2006 Feb 27;24(9):1478-82. doi: 10.1016/j.vaccine.2005.03.059. Epub 2005 Sep 29.
7
Preventative childhood vaccination to rabies.预防儿童狂犬病疫苗接种。
Expert Opin Biol Ther. 2012 Aug;12(8):1067-75. doi: 10.1517/14712598.2012.691162. Epub 2012 Jun 24.
8
Rabies pre-exposure vaccination of children with purified chick embryo cell vaccine (PCECV).儿童狂犬病暴露前预防接种纯化鸡胚细胞疫苗(PCECV)。
Hum Vaccin Immunother. 2013 Jul;9(7):1454-9. doi: 10.4161/hv.24502. Epub 2013 Apr 9.
9
Trend of human rabies prophylaxis in developing countries: toward optimal rabies immunization.发展中国家人类狂犬病预防趋势:走向最佳狂犬病免疫。
Vaccine. 2013 Aug 28;31(38):4079-83. doi: 10.1016/j.vaccine.2013.06.083. Epub 2013 Jul 8.
10
30 Years of rabies vaccination with Rabipur: a summary of clinical data and global experience.Rabipur 狂犬病疫苗接种 30 年:临床数据和全球经验总结。
Expert Rev Vaccines. 2015 Mar;14(3):351-67. doi: 10.1586/14760584.2015.1011134.

引用本文的文献

1
A review of the economics of the prevention and control of rabies. Part 1: Global impact and rabies in humans.狂犬病预防与控制的经济学综述。第1部分:全球影响及人类狂犬病
Pharmacoeconomics. 1998 Oct;14(4):365-83. doi: 10.2165/00019053-199814040-00004.

本文引用的文献

1
Postexposure trial of a human diploid cell strain rabies vaccine.人二倍体细胞狂犬病疫苗暴露后试验。
J Infect Dis. 1980 Aug;142(2):133-8. doi: 10.1093/infdis/142.2.133.
2
Anti-rabies treatments in New Mexico: impact of a comprehensive consultation-biologics system.新墨西哥州的抗狂犬病治疗:综合咨询-生物制品系统的影响
Am J Public Health. 1980 Feb;70(2):128-32. doi: 10.2105/ajph.70.2.128.
3
Neuroparalytic illness and human diploid cell rabies vaccine.神经麻痹性疾病与人二倍体细胞狂犬病疫苗
JAMA. 1982 Dec 17;248(23):3136-8.
4
Intradermal immunization with human diploid cell rabies vaccine. Serological and clinical responses of persons with and without prior vaccination with duck embryo vaccine.人二倍体细胞狂犬病疫苗皮内免疫。既往接种过鸭胚疫苗和未接种过鸭胚疫苗人群的血清学及临床反应。
JAMA. 1982 Oct 1;248(13):1611-4.
5
Human diploid cell rabies vaccine. Effectiveness of immunization with small intradermal or subcutaneous doses.人二倍体细胞狂犬病疫苗。小剂量皮内或皮下免疫的有效性。
JAMA. 1982 Feb 26;247(8):1138-42. doi: 10.1001/jama.247.8.1138.
6
Systematic decision-making in rabies prophylaxis.狂犬病预防中的系统决策
Pediatr Infect Dis. 1983 Mar-Apr;2(2):162-7. doi: 10.1097/00006454-198303000-00021.
7
Animal bites as an occupational hazard among animal control officers.动物咬伤是动物控制官员面临的职业危害。
Am J Public Health. 1984 Mar;74(3):255-6. doi: 10.2105/ajph.74.3.255.
8
The epidemiology of human rabies postexposure prophylaxis, 1980-1981.1980 - 1981年人类狂犬病暴露后预防的流行病学情况
JAMA. 1983 Oct 21;250(15):1990-6.
9
Successful protection of humans exposed to rabies infection. Postexposure treatment with the new human diploid cell rabies vaccine and antirabies serum.成功保护暴露于狂犬病感染的人类。使用新型人二倍体细胞狂犬病疫苗和抗狂犬病血清进行暴露后治疗。
JAMA. 1976 Dec 13;236(24):2751-4.